J Immunology:I型干扰素调控系统性硬化疾病发生

2016-05-31 佚名 生物谷

系统性硬化(systemic sclerosis)是一类复杂的自身免疫疾病,该疾病可以大致分为两类:一类是局部皮肤的硬皮病(limited cutaneous scleroderma),主要是患者的皮肤出现纤维化症状,同时伴随有"雷诺现象"以及肺脏血压升高;另一类是扩散性系统硬化,即患者多处组织器官发生病变。目前对造成该疾病的免疫系统紊乱的机制了解并不清楚,不过最近一些研究发现I型干扰素在多种自体

系统性硬化(systemic sclerosis)是一类复杂的自身免疫疾病,该疾病可以大致分为两类:一类是局部皮肤的硬皮病(limited cutaneous scleroderma),主要是患者的皮肤出现纤维化症状,同时伴随有"雷诺现象"以及肺脏血压升高;另一类是扩散性系统硬化,即患者多处组织器官发生病变。目前对造成该疾病的免疫系统紊乱的机制了解并不清楚,不过最近一些研究发现I型干扰素在多种自体免疫疾病(包括系统性红斑狼疮、肌炎、牛皮癣、 肉样瘤病以及异性糖尿病等等)中发挥了重要的作用。另外,还有一些研究发现在硬皮病患者病变部位存在大量的I型干扰素,然而I型干扰素对该自体免疫病的发病有何作用目前并不清楚。


干扰素可以分为I型、II型以及III型,其中I型干扰素包括IFN-alpha(13个亚型)、IFN-beta、omega以及kappa。抗病毒感染以外,I型干扰素还能够促进DC的成熟,效应CD8+ T细胞的活化,NK细胞的活化以及B细胞的分化等。为了探究I型干扰素在系统性硬化这一疾病中的作用,来自华盛顿大学医学院的Anthony J. Coyle课题组进行了深入研究,相关结果发表在《Journal of immunology》杂志上。
 
首先,作者利用特异性针对IFNR1(I型干扰素受体)的抗体处理经过皮肤移植,发生系统性硬化疾病的小鼠模型(GVHD-SS1),之后观察其疾病的发展情况。结果显示,抗体的处理能够有效降低小鼠的疾病严重程度,这说明I型干扰素的确能够促进自体免疫反应的发生。
 
之后,作者比较了不同处理小鼠血清中自体抗体的产生量。结果显示,在IFNR1抗体处理过的小鼠体内自体反应抗体的含量明显低于对照组,这说明I型IFN能够促进自身反应抗体的产生。
 
那么IFNR1信号通路的阻断是如何影响到自体免疫反应抗体的水平的呢?作者发现IFNR1抗体处理过的小鼠,其自身免疫反应抗体在真皮层中的含量与对照组差异不大,但其在血管层的沉积显著下降。另外,真皮层中C1q的含量差别较为明显,IFNR1抗体处理过的小鼠C1q在真皮层中的含量明显低于对照组。这说明IFNR1的阻断能够有效抑制C1q在真皮层的沉积,并部分影响了自身抗体的积累。
 
进一步,作者比较了GVHD-SS1小鼠在移植手术之后I型干扰素产生的动态特征。结果显示:IFN-beta的表达在1周之后达到最高峰;IFN-alpha9, IFN-gamma, and IFN-lamda2 在三周之后达到高峰;而IFN-gamma在手术之后4周仍然维持峰值,此时皮肤的纤维化已经十分严重。
 
之后,作者分析了在IFNR1信号阻断之后下游基因的表达是否发生变化。结果显示:IFN下游的一些基因在IFNR1受体信号阻断之后发生了明显的下调,进而TNF-alpha以及IL1-6的表达了受到了影响。

最后作者证明了IFNAR1信号对于GVHD-SS1小鼠血管病变发生具有重要的作用。

原始出处:

Tracy A. Delaney*, Chris Morehouse†, P. Zachary Brohawn†, Christopher Groves*, Marco Colonna‡, Yihong Yao§, Miguel Sanjuan* and Anthony J. Coyle¶  Type I IFNs Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-versus-Host Disease The Journal of Immunology  May 25, 2016
1502190

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2016934, encodeId=95d12016934d7, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Thu Feb 02 21:14:00 CST 2017, time=2017-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318217, encodeId=28da131821ebf, content=<a href='/topic/show?id=685a101e4f8' target=_blank style='color:#2F92EE;'>#I型干扰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10174, encryptionId=685a101e4f8, topicName=I型干扰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Jun 02 02:14:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627307, encodeId=da7c162e30732, content=<a href='/topic/show?id=dbcee69217e' target=_blank style='color:#2F92EE;'>#系统性硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76921, encryptionId=dbcee69217e, topicName=系统性硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cf521117287, createdName=yhy100207, createdTime=Thu Jun 02 02:14:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87833, encodeId=1fe48e83325, content=免疫越来越清晰了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Tue May 31 18:45:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2016934, encodeId=95d12016934d7, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Thu Feb 02 21:14:00 CST 2017, time=2017-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318217, encodeId=28da131821ebf, content=<a href='/topic/show?id=685a101e4f8' target=_blank style='color:#2F92EE;'>#I型干扰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10174, encryptionId=685a101e4f8, topicName=I型干扰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Jun 02 02:14:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627307, encodeId=da7c162e30732, content=<a href='/topic/show?id=dbcee69217e' target=_blank style='color:#2F92EE;'>#系统性硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76921, encryptionId=dbcee69217e, topicName=系统性硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cf521117287, createdName=yhy100207, createdTime=Thu Jun 02 02:14:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87833, encodeId=1fe48e83325, content=免疫越来越清晰了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Tue May 31 18:45:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2016934, encodeId=95d12016934d7, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Thu Feb 02 21:14:00 CST 2017, time=2017-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318217, encodeId=28da131821ebf, content=<a href='/topic/show?id=685a101e4f8' target=_blank style='color:#2F92EE;'>#I型干扰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10174, encryptionId=685a101e4f8, topicName=I型干扰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Jun 02 02:14:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627307, encodeId=da7c162e30732, content=<a href='/topic/show?id=dbcee69217e' target=_blank style='color:#2F92EE;'>#系统性硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76921, encryptionId=dbcee69217e, topicName=系统性硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cf521117287, createdName=yhy100207, createdTime=Thu Jun 02 02:14:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87833, encodeId=1fe48e83325, content=免疫越来越清晰了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Tue May 31 18:45:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2016934, encodeId=95d12016934d7, content=<a href='/topic/show?id=9760e69058c' target=_blank style='color:#2F92EE;'>#系统性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76905, encryptionId=9760e69058c, topicName=系统性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Thu Feb 02 21:14:00 CST 2017, time=2017-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1318217, encodeId=28da131821ebf, content=<a href='/topic/show?id=685a101e4f8' target=_blank style='color:#2F92EE;'>#I型干扰素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10174, encryptionId=685a101e4f8, topicName=I型干扰素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3307462, createdName=风铃821, createdTime=Thu Jun 02 02:14:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1627307, encodeId=da7c162e30732, content=<a href='/topic/show?id=dbcee69217e' target=_blank style='color:#2F92EE;'>#系统性硬化#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76921, encryptionId=dbcee69217e, topicName=系统性硬化)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cf521117287, createdName=yhy100207, createdTime=Thu Jun 02 02:14:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=87833, encodeId=1fe48e83325, content=免疫越来越清晰了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Tue May 31 18:45:00 CST 2016, time=2016-05-31, status=1, ipAttribution=)]
    2016-05-31 沉心多思

    免疫越来越清晰了

    0

相关资讯

J Immunol:孙兵等发现负性调控I型干扰素产生的新分子NMI

8月16日,国际学术期刊Journal of Immunology在线发表了中国科学院上海生物化学与细胞生物学研究所孙兵研究组题为“Negative Regulation of Nmi on Virus-Triggered Type I IFN Production by Targeting IRF7”的研究论文。报道了病毒诱导的分子NMI(N-Myc and STATs interactor)可

Cancer Cell:I型干扰素靶向治疗抗体耐药肿瘤研究上的重大成果

2014年1月,中国科学院生物物理所傅阳心课题组在Cancer Cell杂志发表标题为“Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses”的论文。 该论文首度提出IFNβ靶向肿瘤治疗的新策略,即重建肿瘤微环境固有免疫和获得性免疫的协同作用、消除顽固耐